Financials [ 1/12 ] | Capital Markets [ 29/74 ]
NASDAQ | Common Stock
SLR Investment Corp. is a business development company specializing in secured debt (first lien unitranche and second lien), subordinated (unsecured) debt, minority equity, leveraged buyouts, acquisitions, recapitalizations, general refinancing, growth capital and strategic income-oriented control equity investments in leveraged middle market companies.
The fund invests in aerospace and defense; air freight & logistics; asset management; automotive; banking; beverage, food and tobacco; building products; buildings and real estate; broadcasting and entertainment; cargo transport; commercial services and supplies; communications equipment; chemicals, plastics and rubber; containers, packaging and glass; construction & engineering; diversified/conglomerate manufacturing; consumer Finance; distributors; diversified/conglomerate services; diversified financial services; diversified real estate activities; food products; Footwear; Education Services; diversified telecommunications services; electronics; farming and agriculture; finance; grocery; health care equipment and supplies; health care facilities; education and childcare; home and office furnishing, durable consumer products; hotels, motels, inns and gaming; insurance; restaurants, leisure, amusement, and entertainment; leisure equipment tolls and services, media, multiline retail, multi sector holdings; paper and forest products; personal products; professional services, research and consulting services, software; specialty retail; textiles apparel and luxury goods, thrifts and mortgage finance, trading companies and distributors, utilities, and wireless telecommunication services; industrial conglomerates; internet software and services, IT services, machinery; mining, steel, iron, and non-precious metals; oil and gas; personal, food and miscellaneous services; printing and publishing; retail stores; telecommunications; textiles and leather; and utilities.
It also invests in life sciences with focus on specialty pharmaceuticals, medical devices, biotech, healt
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 7, 24 | 0.45 Increased by +9.76% | 0.43 Increased by +4.65% |
| May 8, 24 | 0.44 Increased by +7.32% | 0.43 Increased by +2.33% |
| Feb 27, 24 | 0.44 Increased by +4.76% | 0.43 Increased by +2.33% |
| Nov 7, 23 | 0.42 Increased by +13.51% | 0.43 Decreased by -2.33% |
| Aug 8, 23 | 0.41 Increased by +10.81% | 0.42 Decreased by -2.38% |
| May 10, 23 | 0.41 Increased by +28.12% | 0.42 Decreased by -2.38% |
| Feb 28, 23 | 0.42 Increased by +20.00% | 0.40 Increased by +5.00% |
| Nov 2, 22 | 0.37 Increased by +2.78% | 0.38 Decreased by -2.63% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 59.77 M Increased by +102.56% | N/A Decreased by -100.00% | - - |
| Jun 30, 24 | 59.08 M Increased by +177.41% | 23.23 M Increased by +22.28% | Increased by +39.31% Decreased by -55.92% |
| Mar 31, 24 | 58.23 M Increased by +492.23% | 27.87 M Increased by +308.43% | Increased by +47.86% Decreased by -31.04% |
| Dec 31, 23 | 61.57 M Increased by +172.12% | 23.62 M Decreased by -34.02% | Increased by +38.37% Decreased by -75.75% |
| Sep 30, 23 | 29.51 M Increased by +91.60% | 1.06 M Decreased by -92.14% | Increased by +3.60% Decreased by -95.90% |
| Jun 30, 23 | 21.30 M Increased by +240.50% | 19.00 M Increased by +221.40% | Increased by +89.19% Decreased by -13.59% |
| Mar 31, 23 | 9.83 M Increased by +80.52% | 6.82 M Increased by +366.44% | Increased by +69.40% Increased by +158.38% |
| Dec 31, 22 | 22.63 M Increased by +144.87% | 35.80 M Increased by +485.19% | Increased by +158.23% Increased by +138.98% |